India's health ministry has issued a warning about the potential misuse of cheap, generic weight-loss drugs, such as semaglutide, following the expiry of patents. The government is increasing inspections to ensure safe access to these medications.

• Generic versions of GLP-1 drugs, including semaglutide, are now significantly cheaper, costing 1,300 to 4,200 rupees ($15-$45) per month compared to the previous 15,000 to 22,000 rupees.
• The Ministry of Health and the Drugs Controller of India are actively involved in regulating the pharmaceutical supply chain.
• Concerns exist that these powerful drugs could be used without a doctor's prescription, potentially leading to serious adverse effects.